Humanin
HN / HNG / Humanin G
Humanin is a 24-amino acid mitochondrial-derived peptide (MDP) encoded within the 16S ribosomal RNA gene of mitochondrial DNA, first discovered in 2001 from surviving neurons in Alzheimer's disease brains. It exhibits potent neuroprotective, anti-apoptotic, and cytoprotective properties across multiple organ systems through interactions with IGFBP-3, BAX, and the formyl peptide receptor-like 1 (FPRL1). Research interest has expanded from neurodegeneration to encompass metabolic disease, cardiovascular protection, and aging biology.
作用机制
Mitochondria-derived micropeptide encoded in the 16S rRNA region. Neuroprotective through binding to IGFBP-3 (blocking apoptosis), activating STAT3 signaling, and modulating BAX-mediated cell death. Also improves insulin sensitivity and reduces amyloid-beta toxicity.
研究协议
仅供研究使用,非医疗建议。
Research protocols are primarily preclinical. Humanin analogs (HNG, HNGF6A) used at 1-4mg/kg in animal models. Human dosing not established. Intranasal and subcutaneous routes studied.
研究笔记
Clinical Research Status
Humanin remains in the preclinical and early translational research phase, with no completed human clinical trials as of current literature. Observational studies have found that circulating humanin levels decline with age and correlate inversely with markers of cognitive decline and metabolic dysfunction. Several humanin analogs with enhanced potency and stability, particularly HNG (S14G-Humanin), have been developed to overcome the native peptide's short half-life and advance toward clinical testing.
Key Published Findings
The original discovery by Bhimori Hashimoto (2001) demonstrated that humanin specifically protected neurons against amyloid-beta toxicity, presenilin mutant-induced apoptosis, and other Alzheimer's-related insults. Subsequent research revealed humanin acts as an insulin sensitizer, reducing hepatic glucose production and improving glucose tolerance in animal models of diabetes. Studies in cardiovascular models show humanin protects against ischemia-reperfusion injury, reduces atherosclerotic plaque formation, and inhibits vascular smooth muscle cell apoptosis.
Safety Profile
As an endogenously produced peptide, humanin is considered to have a favorable safety profile, though systematic toxicology studies in humans have not been conducted. The primary theoretical concern involves its anti-apoptotic properties potentially interfering with tumor suppression mechanisms, though some evidence suggests it may actually enhance certain anti-cancer immune responses. No significant adverse effects have been reported in animal studies at supraphysiological doses, though long-term exposure data remains limited.
Comparison to Related Compounds
Humanin is the founding member of the mitochondrial-derived peptide family, which also includes MOTS-c (a 16-amino acid exercise mimetic peptide) and the SHLPs (Small Humanin-Like Peptides 1-6). Unlike exogenous neuroprotective peptides such as Cerebrolysin or Semax, humanin represents an endogenous protective signal that declines with mitochondrial aging. The analog HNG is approximately 1000-fold more potent than native humanin, making it more practical for research applications.
Community Observations
Interest in humanin within longevity research communities centers on its role as a biomarker and potential therapeutic for mitochondrial aging. Due to extremely limited commercial availability and the early stage of research, human experimentation outside academic settings is rare. The peptide's connection to centenarian genetics (elevated humanin levels correlate with exceptional longevity) has generated significant interest in the anti-aging research community.
半衰期
~30-60 minutes
复溶
Sterile saline or bacteriostatic water
存储
冻干
Store at -20C. Sensitive to freeze-thaw cycles.
复溶后
Refrigerate 2-8C. Use within 7 days.
美国法律状态
又称作
最新研究
Highlight the role of humanin and MOTS-c in aging processes and their potential as therapeutic targets for age-related diseases.
Highlighting the emerging role of mitochondria-derived peptides (MDPs) in aging and disease could attract interest from researchers and clinicians interested in novel therapeutic targets.
常见问题
什么是 Humanin?
Humanin is a 24-amino acid mitochondrial-derived peptide (MDP) encoded within the 16S ribosomal RNA gene of mitochondrial DNA, first discovered in 2001 from surviving neurons in Alzheimer's disease brains. It exhibits potent neuroprotective, anti-apoptotic, and cytoprotective properties across multiple organ systems through interactions with IGFBP-3, BAX, and the formyl peptide receptor-like 1 (FPRL1). Research interest has expanded from neurodegeneration to encompass metabolic disease, cardiovascular protection, and aging biology.
Humanin 如何起作用?
Mitochondria-derived micropeptide encoded in the 16S rRNA region. Neuroprotective through binding to IGFBP-3 (blocking apoptosis), activating STAT3 signaling, and modulating BAX-mediated cell death. Also improves insulin sensitivity and reduces amyloid-beta toxicity.
Humanin 在美国的监管状态是什么?
Research chemical (not FDA-approved)
Humanin 的半衰期是多少?
~30-60 minutes
Humanin 还有哪些名称?
HN, HNG, Humanin G
Peptide Contacts仅提供基于研究的摘要,仅供信息参考。我们不托管、分发或支持供应商文档。所有证书分析、GMP证书和供应商通信必须由买家直接请求并验证。本平台上任何内容均不构成法律、医疗或专业建议。用户在购买任何研究化学品之前应自行核实供应商资质,并确保遵守所有适用的当地、州及联邦法律法规,承担全部法律责任。
阅读完整免责声明